Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 171-180 of 202 for melanoma

Edit search filters
  1. Characterizing Ultrasound Vibroelastography Features of Ocular Tumors

    Rochester, MN

  2. A Study to Evaluate Maximizing Anti-PD-1 Therapy By Monitoring T Cell Responses In Melanoma, Lung and Other Cancer Types

    Rochester, MN

  3. Molecular Characterization of Renal Cell Carcinomas and Melanomas

    Scottsdale/Phoenix, AZ, Rochester, MN

  4. A Prospective Ocular Tumor Study

    Rochester, MN

  5. Gut and Tumor Microbiome in Patients With Advanced ER-positive and HER2-negative Breast Cancer or Advanced Melanoma Undergoing PD-1 Checkpoint Inhibitor Therapy.

    Jacksonville, FL

  6. Defining the Immunologic Profile of Sentinel Lymph Nodes and Identifying the Mechanisms Responsible for Immunosuppression

    Rochester, MN, Jacksonville, FL

  7. Congenital Heart Disease Skin Punch Biopsy Sample Collection

    Rochester, MN

  8. Biomarkers to Predict for and Monitor Response to PD-1/PD-L1 Inhibitors

    Rochester, MN, Jacksonville, FL

  9. Spatial and Molecular Architecture of Tumor Environments Responsive to IO (immuno-oncology) Therapy

    Rochester, MN

  10. A Study to Investigate LYL845 in Adults With Solid Tumors

    Rochester, MN

.

Mayo Clinic Footer